[1]
|
Jemal, A., et al. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. https://doi.org/10.3322/caac.20107
|
[2]
|
Shanta, V., et al. (2000) Epidemiology of Cancer of the Cervix: Global and National Perspective. Journal of the Indian Medical Association, 98, 49-52.
|
[3]
|
Bosch, F.X., et al. (2002) The Causal Relation between Human Papillomavirus and Cervical Cancer. Journal of Clinical Pathology, 55, 244-265.
|
[4]
|
Munoz, N., et al. (1992) The Causal Link between Human Papillomavirus and Invasive Cervical Cancer: A Population-Based Case-Control Study in Colombia and Spain. International Journal of Cancer, 52, 743-749.
https://doi.org/10.1002/ijc.2910520513
|
[5]
|
Schiffman, M.H., et al. (1993) Epidemiologic Evidence Showing that Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia. JNCI: Journal of the National Cancer Institute, 85, 958-964. https://doi.org/10.1093/jnci/85.12.958
|
[6]
|
Duenas-González, A., et al. (2005) Epigenetics of Cervical Cancer. An Overview and Therapeutic Perspectives. Molecular Cancer, 4, 38.
https://doi.org/10.1186/1476-4598-4-38
|
[7]
|
Smith, J.S., et al. (2007) Human Papillomavirus Type Distribution in Invasive Cervical Cancer and High-Grade Cervical Lesions: A Meta-Analysis Update. International Journal of Cancer, 121, 621-632. https://doi.org/10.1002/ijc.22527
|
[8]
|
Pagliusi, S.R. and Aguado, M.T. (2004) Efficacy and Other Milestones for Human Papillomavirus Vaccine Introduction. Vaccine, 23, 569-578.
https://doi.org/10.1016/j.vaccine.2004.07.046
|
[9]
|
Franco, E.L., et al. (1999) Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High-Risk Area for Cervical Cancer. The Journal of Infectious Diseases, 180, 1415-1423.
https://doi.org/10.1086/315086
|
[10]
|
Derrien, T., et al. (2012) The GENCODE v7 Catalog of Human Long Noncoding RNAs: Analysis of Their Gene Structure, Evolution, and Expression. Genome Research, 22, 1775-1789. https://doi.org/10.1101/gr.132159.111
|
[11]
|
Mercer, T.R., Dinger, M.E. and Mattick, J.S. (2009) Long Non-Coding RNAs: Insights into Functions. Nature Reviews Genetics, 10, 155-159.
https://doi.org/10.1038/nrg2521
|
[12]
|
Wang, K.C. and Chang, H.Y. (2011) Molecular Mechanisms of Long Noncoding RNAs. Molecular Cell, 43, 904-914. https://doi.org/10.1016/j.molcel.2011.08.018
|
[13]
|
Mercer, T.R. and Mattick, J.S. (2013) Structure and Function of Long Noncoding RNAs in Epigenetic Regulation. Nature Structural & Molecular Biology, 20, 300-307. https://doi.org/10.1038/nsmb.2480
|
[14]
|
Li, J.-H., et al. (2013) starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and Protein-RNA Interaction Networks from Large-Scale CLIP-Seq Data. Nucleic Acids Research, 42, D92-D97. https://doi.org/10.1093/nar/gkt1248
|
[15]
|
Klattenhoff, C.A., et al. (2013) Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment. Cell, 152, 570-583.
https://doi.org/10.1016/j.cell.2013.01.003
|
[16]
|
Bhan, A. and Mandal, S.S. (2015) lncRNA HOTAIR: A Master Regulator of Chromatin Dynamics and Cancer. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1856, 151-164. https://doi.org/10.1016/j.bbcan.2015.07.001
|
[17]
|
KIm, H.J., et al. (2015) Long Non-Coding RNA HOTAIR Is Associated with Human Cervical Cancer Progression. International Journal of Oncology, 46, 521-530.
https://doi.org/10.3892/ijo.2014.2758
|
[18]
|
Pasmant, E., et al. (2007) Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF. Cancer Research, 67, 3963-3969.
https://doi.org/10.1158/0008-5472.CAN-06-2004
|
[19]
|
Zhang, D., et al. (2017) Long Non-Coding RNA ANRIL Indicates a Poor Prognosis of Cervical Cancer and Promotes Carcinogenesis via PI3K/Akt Pathways. Biomedicine & Pharmacotherapy, 85, 511-516. https://doi.org/10.1016/j.biopha.2016.11.058
|
[20]
|
Ji, P., et al. (2003) MALAT-1, a Novel Noncoding RNA, and Thymosin β4 Predict Metastasis and Survival in Early-Stage Non-Small Cell Lung Cancer. Oncogene, 22, 8031-8041. https://doi.org/10.1038/sj.onc.1206928
|
[21]
|
Zhang, Y., et al. (2015) Human MALAT-1 Long Non-Coding RNA Is Overexpressed in Cervical Cancer Metastasis and Promotes Cell Proliferation, Invasion and Migration. J. Buon, 20, 1497-1503.
|
[22]
|
Wang, Y., et al. (2012) Long Non-Coding RNA UCA1a (CUDR) Promotes Proliferation and Tumorigenesis of Bladder Cancer. International Journal of Oncology, 41, 276-284.
|
[23]
|
Han, Y., et al. (2014) UCA1, a Long Non-Coding RNA Up-Regulated in Colorectal Cancer Influences Cell Proliferation, Apoptosis and Cell Cycle Distribution. Pathology—Journal of the RCPA, 46, 396-401.
|
[24]
|
Miyoshi, N., et al. (2000) Identification of an Imprinted Gene, Meg3/Gtl2 and Its Human Homologue MEG3, First Mapped on Mouse Distal Chromosome 12 and Human Chromosome 14q. Genes to Cells, 5, 211-220.
https://doi.org/10.1046/j.1365-2443.2000.00320.x
|
[25]
|
Zhang, J., et al. (2017) Downregulation of Long Noncoding RNA MEG3 Is Associated with Poor Prognosis and Promoter Hypermethylation in Cervical Cancer. Journal of Experimental & Clinical Cancer Research, 36, 5.
https://doi.org/10.1186/s13046-016-0472-2
|
[26]
|
Yang, Y.-R., et al. (2014) Increased Expression of The lncRNA PVT1 Promotes Tumorigenesis in Non-Small Cell Lung Cancer. International Journal of Clinical and Experimental Pathology, 7, 6929.
|
[27]
|
Yang, J., et al. (2016) Long Noncoding RNA PVT1 as a Novel Serum Biomarker for Detection of Cervical Cancer. European Review for Medical and Pharmacological Sciences, 20, 3980-3986.
|
[28]
|
Ling, H., et al. (2013) CCAT2, a Novel Noncoding RNA Mapping to 8q24, Underlies Metastatic Progression and Chromosomal Instability in Colon Cancer. Genome Research, 23, 1446-1461. https://doi.org/10.1101/gr.152942.112
|
[29]
|
Wang, D., et al. (2017) Long Noncoding RNA CCAT2 as a Novel Biomaker of Metastasis and Prognosis in Human Cancer: A Meta-Analysis. Oncotarget, 8, 75664.
https://doi.org/10.18632/oncotarget.18161
|
[30]
|
Chen, X., Liu, L. and Zhu, W. (2015) Up-Regulation of Long Non-Coding RNA CCAT2 Correlates with Tumor Metastasis and Poor Prognosis in Cervical Squamous Cell Cancer Patients. International Journal of Clinical and Experimental Pathology, 8, 13261.
|
[31]
|
Yang, M., et al. (2015) Long Noncoding RNA CCHE1 Promotes Cervical Cancer Cell Proliferation via Upregulating PCNA. Tumor Biology, 36, 7615-7622.
https://doi.org/10.1007/s13277-015-3465-4
|
[32]
|
Chen, Y., et al. (2017) Long Non-Coding RNA CCHE1 Overexpression Predicts a Poor Prognosis for Cervical Cancer. European Review for Medical and Pharmacological Sciences, 21, 479-483.
|
[33]
|
Peng, W., Wu, J. and Feng, J. (2016) Long Noncoding RNA HULC Predicts Poor Clinical Outcome and Represents Pro-Oncogenic Activity in Diffuse Large B-Cell Lymphoma. Biomedicine & Pharmacotherapy, 79, 188-193.
https://doi.org/10.1016/j.biopha.2016.02.032
|
[34]
|
Wang, Y., et al. (2016) Expression of lncRNA HULC in Cervical Cancer and Its Correlation with Tumor Progression and Patient Survival. European Review for Medical and Pharmacological Sciences, 20, 3987-3991.
|
[35]
|
Li, W., et al. (2017) Systematic Review and Meta-Analysis of the Utility of Long Non-Coding RNA GAS5 as a Diagnostic and Prognostic Cancer Biomarker. Oncotarget, 8, 66414. https://doi.org/10.18632/oncotarget.19040
|
[36]
|
Cao, S., et al. (2014) Decreased Expression of lncRNA GAS5 Predicts a Poor Prognosis in Cervical Cancer. International Journal of Clinical and Experimental Pathology, 7, 6776.
|
[37]
|
Guo, F., et al. (2010) Inhibition of Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Caski Human Cervical Cancer Cells Suppresses Cell Proliferation and Invasion. Acta Biochimica et Biophysica Sinica, 42, 224-229.
https://doi.org/10.1093/abbs/gmq008
|
[38]
|
Yang, L., et al. (2015) High MALAT1 Expression Predicts a Poor Prognosis of Cervical Cancer and Promotes Cancer Cell Growth and Invasion. European Review for Medical and Pharmacological Sciences, 19, 3187-3193.
|
[39]
|
Rinn, J.L., et al. (2007) Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs. Cell, 129, 1311-1323.
https://doi.org/10.1016/j.cell.2007.05.022
|
[40]
|
Hung, T. and Chang, H.Y. (2010) Long Noncoding RNA in Genome Regulation: Prospects and Mechanisms. RNA Biology, 7, 582-585.
https://doi.org/10.4161/rna.7.5.13216
|
[41]
|
Nie, Y., et al. (2013) Long Non-Coding RNA HOTAIR Is an Independent Prognostic Marker for Nasopharyngeal Carcinoma Progression and Survival. Cancer Science, 104, 458-464. https://doi.org/10.1111/cas.12092
|
[42]
|
Kim, H., et al. (2014) Long Noncoding RNA HOTAIR Is Associated with Human Cervical Cancer Progression. Gynecologic Oncology, 133, 5.
https://doi.org/10.1016/j.ygyno.2014.03.027
|
[43]
|
Burton, P.R., et al. (2007) Genome-Wide Association Study of 14,000 Cases of Seven Common Diseases and 3,000 Shared Controls. Nature, 447, 661-678.
https://doi.org/10.1038/nature05911
|
[44]
|
Broadbent, H.M., et al. (2007) Susceptibility to Coronary Artery Disease and Diabetes Is Encoded by Distinct, Tightly Linked SNPs in the ANRIL Locus on Chromosome 9p. Human Molecular Genetics, 17, 806-814.
https://doi.org/10.1093/hmg/ddm352
|
[45]
|
Sherborne, A.L., et al. (2010) Variation in CDKN2A at 9p21.3 Influences Childhood Acute Lymphoblastic Leukemia Risk. Nature Genetics, 42, 492-494.
https://doi.org/10.1038/ng.585
|
[46]
|
Turnbull, C., et al. (2010) Genome-Wide Association Study Identifies Five New Breast Cancer Susceptibility Loci. Nature Genetics, 42, 504-507.
https://doi.org/10.1038/ng.586
|
[47]
|
Gayther, S.A., et al. (2007) Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer. Cancer Research, 67, 3027-3035. https://doi.org/10.1158/0008-5472.CAN-06-3261
|
[48]
|
Yeh, I. and Bastian, B.C. (2009) Genome-Wide Associations Studies for Melanoma and Nevi. Pigment Cell & Melanoma Research, 22, 527.
https://doi.org/10.1111/j.1755-148X.2009.00622.x
|
[49]
|
Cugino, D., et al. (2012) Type 2 Diabetes and Polymorphisms on Chromosome 9p21: A Meta-Analysis. Nutrition, Metabolism and Cardiovascular Diseases, 22, 619-625. https://doi.org/10.1016/j.numecd.2010.11.010
|
[50]
|
Emanuele, E., et al. (2011) Chromosome 9p21.3 Genotype Is Associated with Vascular Dementia and Alzheimer’s Disease. Neurobiology of Aging, 32, 1231-1235.
https://doi.org/10.1016/j.neurobiolaging.2009.07.003
|
[51]
|
Congrains, A., et al. (2013) ANRIL: Molecular Mechanisms and Implications in Human Health. International Journal of Molecular Sciences, 14, 1278-1292.
https://doi.org/10.3390/ijms14011278
|
[52]
|
Wan, G., et al. (2013) Long Non-Coding RNA ANRIL (CDKN2B-AS) Is Induced by the ATM-E2F1 Signaling Pathway. Cellular Signalling, 25, 1086-1095.
https://doi.org/10.1016/j.cellsig.2013.02.006
|
[53]
|
Kotake, Y., et al. (2011) Long Non-Coding RNA ANRIL Is Required for the PRC2 Recruitment to and Silencing of p15INK4B Tumor Suppressor Gene. Oncogene, 30, 1956-1962. https://doi.org/10.1038/onc.2010.568
|
[54]
|
Qiu, J.-J., et al. (2016) The Long Non-Coding RNA ANRIL Promotes Proliferation and Cell Cycle Progression and Inhibits Apoptosis and Senescence in Epithelial Ovarian Cancer. Oncotarget, 7, 32478. https://doi.org/10.18632/oncotarget.8744
|
[55]
|
Naemura, M., et al. (2015) Long Noncoding RNA ANRIL Regulates Proliferation of Non-Small Cell Lung Cancer and Cervical Cancer Cells. Anticancer Research, 35, 5377-5382.
|
[56]
|
Schuster-Gossler, K., et al. (1998) The Mouse Gtl2 Gene Is Differentially Expressed during Embryonic Development, Encodes Multiple Alternatively Spliced Transcripts, and May Act as an RNA. Developmental Dynamics, 212, 214-228.
https://doi.org/10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K
|
[57]
|
Zhang, X., et al. (2003) A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells. The Journal of Clinical Endocrinology & Metabolism, 88, 5119-5126. https://doi.org/10.1210/jc.2003-030222
|
[58]
|
Zhao, J., et al. (2005) Hypermethylation of the Promoter Region Is Associated with the Loss of MEG3 Gene Expression in Human Pituitary Tumors. The Journal of Clinical Endocrinology & Metabolism, 90, 2179-2186.
https://doi.org/10.1210/jc.2004-1848
|
[59]
|
Benetatos, L., et al. (2008) Promoter Hypermethylation of the MEG3 (DLK1/MEG3) Imprinted Gene in Multiple Myeloma. Clinical Lymphoma and Myeloma, 8, 171-175. https://doi.org/10.3816/CLM.2008.n.021
|
[60]
|
Vousden, K.H. and Prives, C. (2009) Blinded by the Light: The Growing Complexity of p53. Cell, 137, 413-431. https://doi.org/10.1016/j.cell.2009.04.037
|
[61]
|
Benetatos, L., Vartholomatos, G. and Hatzimichael, E. (2011) MEG3 Imprinted Gene Contribution in Tumorigenesis. International Journal of Cancer, 129, 773-779. https://doi.org/10.1002/ijc.26052
|
[62]
|
Kruer, T.L., et al. (2016) Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway. PLoS ONE, 11, e0166363. https://doi.org/10.1371/journal.pone.0166363
|
[63]
|
Qin, R., et al. (2013) Long Non-Coding RNA MEG3 Inhibits the Proliferation of Cervical Carcinoma Cells through the Induction of Cell Cycle Arrest and Apoptosis. Neoplasma, 60, 486-492. https://doi.org/10.4149/neo_2013_063
|
[64]
|
Zhang, J., et al. (2016) Long Noncoding RNA MEG3 Is Downregulated in Cervical Cancer and Affects Cell Proliferation and Apoptosis by Regulating miR-21. Cancer Biology & Therapy, 17, 104-113. https://doi.org/10.1080/15384047.2015.1108496
|
[65]
|
Schneider, C., King, R.M. and Philipson, L. (1988) Genes Specifically Expressed at Growth Arrest of Mammalian Cells. Cell, 54, 787-793.
https://doi.org/10.1016/S0092-8674(88)91065-3
|
[66]
|
Pickard, M.R. and Williams, G.T. (2016) The Hormone Response Element Mimic Sequence of GAS5 lncRNA Is Sufficient to Induce Apoptosis in Breast Cancer Cells. Oncotarget, 7, 10104. https://doi.org/10.18632/oncotarget.7173
|
[67]
|
Shi, X., et al. (2015) A Critical Role for the Long Non-Coding RNA GAS5 in Proliferation and Apoptosis in Non-Small-Cell Lung Cancer. Molecular Carcinogenesis, 54, E1-E12. https://doi.org/10.1002/mc.22120
|
[68]
|
Pickard, M., Mourtada-Maarabouni, M. and Williams, G. (2013) Long Non-Coding RNA GAS5 Regulates Apoptosis in Prostate Cancer Cell Lines. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1832, 1613-1623.
https://doi.org/10.1016/j.bbadis.2013.05.005
|
[69]
|
Liu, Z., et al. (2013) Downregulation of GAS5 Promotes Bladder Cancer Cell Proliferation, Partly by Regulating CDK6. PLoS ONE, 8, e73991.
https://doi.org/10.1371/journal.pone.0073991
|
[70]
|
Fraser, M., Bai, T. and Tsang, B.K. (2008) Akt Promotes Cisplatin Resistance in Human Ovarian Cancer Cells through Inhibition of p53 Phosphorylation and Nuclear Function. International Journal of Cancer, 122, 534-546.
https://doi.org/10.1002/ijc.23086
|
[71]
|
Wen, Q., et al. (2017) Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via MicroRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer. International Journal of Gynecological Cancer, 27, 1096.
https://doi.org/10.1097/IGC.0000000000001028
|
[72]
|
Qiu, M., et al. (2014) CCAT2 Is a Lung Adenocarcinoma-Specific Long Non-Coding RNA and Promotes Invasion of Non-Small Cell Lung Cancer. Tumor Biology, 35, 5375-5380. https://doi.org/10.1007/s13277-014-1700-z
|
[73]
|
Redis, R.S., et al. (2013) CCAT2, a Novel Long Non-Coding RNA in Breast Cancer: Expression Study and Clinical Correlations. Oncotarget, 4, 1748.
https://doi.org/10.18632/oncotarget.1292
|
[74]
|
Wang, C.-Y., et al. (2015) Long Non-Coding RNA CCAT2 Is Up-Regulated in Gastric Cancer and Associated with Poor Prognosis. International Journal of Clinical and Experimental Pathology, 8, 779.
|
[75]
|
Huang, S., et al. (2016) The Long Non-Coding RNA CCAT2 Is Up-Regulated in Ovarian Cancer and Associated with Poor Prognosis. Diagnostic Pathology, 11, 49.
https://doi.org/10.1186/s13000-016-0499-x
|
[76]
|
Nan, H., et al. (2013) Aspirin Use, 8q24 Single Nucleotide Polymorphism rs6983 267, and Colorectal Cancer According to CTNNB1 Alterations. Journal of the National Cancer Institute, 105, 1852-1861. https://doi.org/10.1093/jnci/djt331
|
[77]
|
Peng, Y., et al. (2017) The Crosstalk between MicroRNAs and the Wnt/β-Catenin Signaling Pathway in Cancer. Oncotarget, 8, 14089.
https://doi.org/10.18632/oncotarget.12923
|
[78]
|
Rennoll, S. and Yochum, G. (2015) Regulation of Myc Gene Expression by Aberrant Wnt/β-Catenin Signaling in Colorectal Cancer. World Journal of Biological Chemistry, 6, 290. https://doi.org/10.4331/wjbc.v6.i4.290
|
[79]
|
Cai, Y., He, J. and Zhang, D. (2015) Long Noncoding RNA CCAT2 Promotes Breast Tumor Growth by Regulating the Wnt Signaling Pathway. OncoTargets and Therapy, 8, 2657.
|
[80]
|
Kokka, F., et al. (2013) Surgical Treatment of Stage IA2 Cervical Cancer. The Cochrane Database of Systematic Reviews, 5, CD010870.
|
[81]
|
Le Wu, L.J., Zhang, W. and Zhang, L. (2016) Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 22, 875.
https://doi.org/10.12659/MSM.897754
|
[82]
|
Xue, M., Chen, W. and Li, X. (2016) Urothelial Cancer Associated 1: A Long Noncoding RNA with a Crucial Role in Cancer. Journal of Cancer Research and Clinical Oncology, 142, 1407-1419. https://doi.org/10.1007/s00432-015-2042-y
|
[83]
|
Tsang, W.P., et al. (2007) Induction of Drug Resistance and Transformation in Human Cancer Cells by the Noncoding RNA CUDR. RNA, 13, 890-898.
https://doi.org/10.1261/rna.359007
|
[84]
|
Wang, X.-S., et al. (2006) Rapid Identification of UCA1 as a Very Sensitive and Specific Unique Marker for Human Bladder Carcinoma. Clinical Cancer Research, 12, 4851-4858. https://doi.org/10.1158/1078-0432.CCR-06-0134
|
[85]
|
Wang, F., et al. (2008) UCA1, a Non-Protein-Coding RNA Up-Regulated in Bladder Carcinoma and Embryo, Influencing Cell Growth and Promoting Invasion. FEBS Letters, 582, 1919-1927. https://doi.org/10.1016/j.febslet.2008.05.012
|
[86]
|
Wang, F., et al. (2015) Upregulated lncRNA-UCA1 Contributes to Progression of Hepatocellular Carcinoma through Inhibition of MiR-216b and Activation of FGFR1/ERK Signaling Pathway. Oncotarget, 6, 7899.
https://doi.org/10.18632/oncotarget.3219
|
[87]
|
Huang, J., et al. (2015) Long Non-Coding RNA UCA1 Promotes Breast Tumor Growth by Suppression of p27 (Kip1). Cell Death & Disease, 5, e1008.
https://doi.org/10.1038/cddis.2013.541
|
[88]
|
Zheng, Q., et al. (2015) Aberrant Expression of UCA1 in Gastric Cancer and Its Clinical Significance. Clinical and Translational Oncology, 17, 640-646.
https://doi.org/10.1007/s12094-015-1290-2
|
[89]
|
Li, J.-Y., Ma, X. and Zhang, C.-B. (2014) Overexpression of Long Non-Coding RNA UCA1 Predicts a Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. International Journal of Clinical and Experimental Pathology, 7, 7938.
|
[90]
|
Fang, Z., et al. (2014) Increased Expression of the Long Non-Coding RNA UCA1 in Tongue Squamous Cell Carcinomas: A Possible Correlation with Cancer Metastasis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 117, 89-95.
https://doi.org/10.1016/j.oooo.2013.09.007
|
[91]
|
Wang, B., et al. (2017) Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer. Cancer Biotherapy and Radiopharmaceuticals, 32, 101-110. https://doi.org/10.1089/cbr.2016.2156
|
[92]
|
Beck-Engeser, G.B., et al. (2008) PVT1-Encoded MicroRNAs in Oncogenesis. Retrovirology, 5, 4. https://doi.org/10.1186/1742-4690-5-4
|
[93]
|
Guan, Y., et al. (2007) Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer. Clinical Cancer Research, 13, 5745-5755.
https://doi.org/10.1158/1078-0432.CCR-06-2882
|
[94]
|
Webb, E., Adams, J.M. and Cory, S. (1984) Variant (6:15) Translocation in a Murine Plasmacytoma Occurs near an Immunoglobulin κ Gene but Far from the Myc Oncogene. Nature, 312, 777-779. https://doi.org/10.1038/312777a0
|
[95]
|
Graham, M. and Adams, J.M. (1986) Chromosome 8 Breakpoint Far 3’ of the C-Myc Oncogene in a Burkitt’s lymphoma 2:8 Variant Translocation Is Equivalent to the Murine PVT-1 Locus. The EMBO Journal, 5, 2845.
|
[96]
|
Shtivelman, E. and Bishop, J. (1990) Effects of Translocations on Transcription from PVT. Molecular and Cellular Biology, 10, 1835-1839.
https://doi.org/10.1128/MCB.10.4.1835
|
[97]
|
Ding, J., et al. (2014) Expression and Clinical Significance of the Long Non-Coding RNA PVT1 in Human Gastric Cancer. OncoTargets and Therapy, 7, 1625.
https://doi.org/10.2147/OTT.S68854
|
[98]
|
Ding, C., et al. (2015) Long Non-Coding RNA PVT1 Is Associated with Tumor Progression and Predicts Recurrence in Hepatocellular Carcinoma Patients. Oncology Letters, 9, 955-963. https://doi.org/10.3892/ol.2014.2730
|
[99]
|
Huang, C., et al. (2015) Increased Expression of The lncRNA PVT1 Is Associated with Poor Prognosis in Pancreatic Cancer Patients. Minerva Medica, 106, 143-149.
|
[100]
|
Haverty, P.M., et al. (2009) High-Resolution Analysis of Copy Number Alterations and Associated Expression Changes in Ovarian Tumors. BMC Medical Genomics, 2, 21. https://doi.org/10.1186/1755-8794-2-21
|
[101]
|
Wang, F., et al. (2014) Oncofetal Long Noncoding RNA PVT1 Promotes Proliferation and Stem Cell-Like Property of Hepatocellular Carcinoma Cells by Stabilizing NOP2. Hepatology, 60, 1278-1290. https://doi.org/10.1002/hep.27239
|
[102]
|
Takahashi, Y., et al. (2014) Amplification of PVT-1 Is Involved in Poor Prognosis via Apoptosis Inhibition in Colorectal Cancers. British Journal of Cancer, 110, 164-171. https://doi.org/10.1038/bjc.2013.698
|
[103]
|
Cerami, E., et al. (2012) The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2, 401-404.
|
[104]
|
Gao, J., et al. (2013) Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Science Signaling, 6, pl1.
https://doi.org/10.1126/scisignal.2004088
|
[105]
|
Zhang, S., Zhang, G. and Liu, J. (2016) Long Noncoding RNA PVT1 Promotes Cervical Cancer Progression through Epigenetically Silencing miR-200b. Journal of Pathology, Microbiology and Immunology (APMIS), 124, 649-658.
https://doi.org/10.1111/apm.12555
|
[106]
|
Iden, M., et al. (2016) The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis. PLoS ONE, 11, e0156274.
https://doi.org/10.1371/journal.pone.0156274
|
[107]
|
Liu, Y., et al. (2012) A Genetic Variant in Long Non-Coding RNA HULC Contributes to Risk of HBV-Related Hepatocellular Carcinoma in a Chinese Population. PLoS ONE, 7, e35145. https://doi.org/10.1371/journal.pone.0035145
|
[108]
|
Yang, X.-J., et al. (2016) Long Noncoding RNA HULC Promotes Colorectal Carcinoma Progression through Epigenetically Repressing NKD2 Expression. Gene, 592, 172-178. https://doi.org/10.1016/j.gene.2016.08.002
|
[109]
|
Uzan, V.R.M., et al. (2016) High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients. PLoS ONE, 11, e0156774.
https://doi.org/10.1371/journal.pone.0156774
|
[110]
|
Sun, W., et al. (2016) Roles of Long Noncoding RNAs in Gastric Cancer and Their Clinical Applications. Journal of Cancer Research and Clinical Oncology, 142, 2231-2237. https://doi.org/10.1007/s00432-016-2183-7
|